Table 3.

Bacterial species and resistance traits of 230 isolates obtained from blood and lower respiratory tract of 121 patients

	All infections		Blood		Lower respiratory tract
	N of isolates	Resistant, n (%)	N of isolates	Resistant n (%)	N of isolates	Resistant n (%)
Enterobacterales (all)	67	46 (68.7) 3GCRa	22	15 (68.2) 3GCR	45	31 (68.9) 3GCR
		23 (34.3) CREb		8 (36.4) CRE		15 (33.3) CRE
Klebsiella pneumoniae	37	32 (86.5) 3GCR	12	10 (83.3) 3GCR	25	22 (88.0) 3GCR
		22 (59.5) CRc		8 (66.6) CR		14 (56.0) CRE
Escherichia coli	10	7 (70.0) 3GCR	6	3 (50.0) 3GCR	4	4 (100) 3GCR
		0 (0) CR		0 (0) CR		0 (0) CRE
Other Enterobacterales	20	7 (35.0) 3GCR	4	2 (50.0) 3GCR	16	5 (31.2) 3GCR
		1 (5.0) CR		0 (0) CR		1 (6.2%) CR
Acinetobacter baumannii	45	43 (95.5) CRABd	16	15 (93.7) CRAB	29	28 (93.3) CRAB
Pseudomonas aeruginosa	26	9 (34.6) CR	7	1 (12.5) CR	19	8 (42.1) CRe
Enterococci (all)	43	0 (0) VREf	34	0 (0) VRE	9	0 (0) VRE
Enterococcus faecalis	28	0 (0) VRE	22	0 (0) VR	6	0 (0) VRE
Enterococcus faecium	15	0 (0) VRE	12	0 (0) VRE	3	0 (0) VRE
Staphylococcus aureus	34	17 (50.0) MRSAg	13	7 (53.8) MRSA	21	10 (47.6) MRSA
Other bacterial species	15	4 (26.6) MDROh	5	1 (20.0) MDROi	10	3 (30.0) MDROj

^a3GCR: resistant to 3rd generation cephalosporins

^bCRE: Enterobacterales resistant to carbapenems

^cCR: resistant to carbapenems

^dCRAB: Acinetobacter baumannii resistant to carbapenems

^eIncluding 2 cases with carbapenem resistance acquired during carbapenem treatment

^fVRE: Enterococcus spp. resistant to vancomycin

^gMRSA: methicillin/oxacillin resistant Staphylococcus aureus

^hMDRO: resistant to ceftazidime and carbapenems

ⁱ1 Bacteroides fragilis resistant to ceftazidime and carbapenems

^j2 Stenotrophomonas maltophilia and 1 Crysobacterium meningosepticum resistant to ceftazidime and carbapenems